Literature DB >> 933411

Physostigmine--its use and abuse.

W E Walker, R C Levy, I B Hanenson.   

Abstract

Physostigmine salicylate, a cholinesterase inhibitor, has been shown to reverse the effects of certain drugs with anticholinergic properties. The paper provides a brief historical account of physostigmine, reviews the cholinergic drugs and their effects and suggests a management protocol based on physiologic criteria. Twenty-six overdose cases, recently treated with physostigmine, are summarized. The controversy regarding the etiology of seizures following physostigmine administration is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 933411     DOI: 10.1016/s0361-1124(76)80253-5

Source DB:  PubMed          Journal:  JACEP        ISSN: 0361-1124


  2 in total

1.  Physostigmine is the antidote for anticholinergic syndrome.

Authors:  Philip W Moore; J J Rasimas; J W Donovan
Journal:  J Med Toxicol       Date:  2015-03

2.  Timing and frequency of physostigmine redosing for antimuscarinic toxicity.

Authors:  Christopher Rosenbaum; Steven B Bird
Journal:  J Med Toxicol       Date:  2010-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.